The physician group is asking the Labor Department to apply Medicare Advantage plan-type rules, which as limits on repeat reviews for patients with chronic conditions, on ERISA plans.

The bipartisan legislation could affect 275 drugs, everything from the supply of weight-loss drugs to the supply of injectable saline solutions.

The price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health and Human Services report.

State insurance commissioners see “level-funded” plans – hybrid self-insured plans – pulling covered lives away.

Americans surveyed were also most likely to consider buying coverage from the Blues.

The Treasury and Labor officials will work with HHS officials on everything from drug costs to surprise billing.

The proposal would affect Medicare plans directly, and CMS is asking for comments on how it might affect employer plans.

Rep. Lori Chavez-DeRemer also introduced a federal fertility benefits mandate bill.